Consult the medical resource doctors trust
UpToDate is one of the most respected medical information resources in the world, used by over 400,000 doctors and thousands of patients to find answers to medical questions.
Related articles
| AuthorMark A Peppercorn, MD | Section EditorJ Thomas LaMont, MD | Deputy EditorCarla H Ginsburg, MD, MPH, AGAF |
Contents of this article
INTRODUCTION
Crohn's disease is a condition that affects the digestive tract. The cause of Crohn's disease is unknown. The most common symptoms of Crohn's disease include mouth sores, diarrhea, abdominal pain, weight loss, and fever. Some people with Crohn's disease also have problems outside of the digestive tract, including a skin rash, joint pain, eye redness, and, less commonly, liver problems.
There is no cure for Crohn's disease, but there are medicines that can help to keep the disease under control. If medicine does not control symptoms, surgery might be an option to remove the diseased part of the colon.
This article discusses the symptoms and treatment of Crohn's disease. More detailed information about Crohn's disease is available by subscription. (See "Medical management of Crohn's disease in adults" and "Surgical management of inflammatory bowel disease".)
WHAT IS CROHN'S DISEASE?
Crohn's disease is an autoimmune disease, but the precise cause is not known. Having family members with Crohn's disease probably increases the risk of developing the condition. When a person with this inherited risk is exposed to a trigger (an illness or something in the environment), the immune system is activated.
In people with Crohn's disease, the immune system recognizes the lining of the digestive tract as foreign and attacks it, causing inflammation. This inflammation causes the lining of the digestive tract to develop ulcers and bleed. Crohn's disease usually affects the colon and ileum, but it can affect the entire digestive tract, from the mouth to the anus (figure 1).
Crohn's disease is related to ulcerative colitis, another form of inflammatory bowel disease (IBD). Inflammatory bowel disease should not be confused with irritable bowel syndrome (IBS). (See "Patient information: Ulcerative colitis" and "Patient information: Irritable bowel syndrome".)
Will I get better? — Crohn's disease usually follows a pattern of:
About 10 to 20 percent of people will have a remission after their first flare of Crohn's disease. The pattern can be variable, with repeated bouts (weeks to months) of symptoms, such as mild diarrhea and cramping. Less commonly, there can be severe and disabling symptoms (such as severe abdominal pain and a blockage in the bowels). Lifelong treatment is needed for people with Crohn's disease, and treatment increases the chance of entering and staying in remission.
CROHN'S DISEASE SYMPTOMS
The most common symptoms of Crohn's disease include abdominal pain, diarrhea, fatigue, and weight loss. Other symptoms can include mouth sores, skin problems, eye inflammation, and anal problems, such as fistulas and abscesses.
Anal problems sometimes heal on their own without treatment. In other cases, treatment with medicines or surgery will be required. Soaking your bottom in warm water a few times a day and gently cleaning the area can help to speed healing.
CROHN'S DISEASE MEDICATIONS
There are a number of medicines used to treat Crohn's disease. The "best" medicine depends upon which part of the digestive tract is causing symptoms. The following is a summary of commonly used medications. (See "Medical management of Crohn's disease in adults".)
5-aminosalicylates — The 5-aminosalicylates (abbreviated 5-ASA) are a group of medicines that reduce inflammation in the digestive tract. 5-ASA medicines are usually used first to treat a flare and may be recommended continuously to prevent new flares. Mesalamine (sold as Asacol® and Pentasa®) is the most commonly used 5-ASA. (See "Patient information: Sulfasalazine and the 5-aminosalicylates".)
Antibiotics — If 5-ASA medicines do not control your symptoms, your doctor or nurse may recommend a course of antibiotics. Antibiotics can reduce the number of bacteria in the intestines, which may help to reduce inflammation. (See "Antibiotics for treatment of inflammatory bowel diseases".)
Steroids — A type of medicine called steroids (such as prednisone and budesonide) may be recommended if you do not respond to 5-ASAs or antibiotics, or if you have severe symptoms. Steroids are usually used for a limited time to get the inflammation under control, and are then slowly stopped. Steroids are not usually recommended long-term because of the risk of side effects.
Immunomodulators — Immunomodulators help to reduce the inflammation associated with Crohn's disease. Immunomodulators might be recommended if you have severe symptoms or do not improve with steroids, or if your symptoms worsen after decreasing your steroid dose. The most commonly used immunomodulators include azathioprine, 6-mercaptopurine, and methotrexate. (See "Immunomodulator therapy in Crohn's disease".)
Biologic response modifiers — Biologic response modifiers are a class of medicines that work by preventing inflammation. These medicines are often used in combination with treatments described above.
Biologic response modifiers are costly and can have serious side effects (see 'Side effects' below). As a result, biologic response modifiers are generally reserved for people with severe symptoms who have not responded to other treatments.
All biologic response modifiers are given as an injection; some can be given at home, while others must be given in a doctor's office. The most commonly used biologic response modifiers include:
Side effects — Biologic response modifiers interfere with the immune system's ability to fight infection and should not be used in people with serious infections. Testing for tuberculosis (TB) is needed before starting treatment since treatment can "activate" TB if you have been exposed to TB previously. (See "Patient information: Tuberculosis".)
Biologic response modifiers are not recommended for people who currently have or have previously had lymphoma (a type of cancer). Some studies have reported an association between these drugs and a higher risk of developing lymphoma. More research is needed in this area.
SURGERY FOR CROHN'S DISEASE
Medicines can help control the symptoms and complications of Crohn's disease and can help you to avoid or postpone surgery. However, surgery may be recommended if your symptoms are not controlled with medicine or if the side effects of medicine are unbearable. About 80 percent of people with Crohn's disease will need surgery at some point in their life. (See "Surgical management of inflammatory bowel disease".)
It is important to have realistic expectations of surgery. Surgery does not cure Crohn's disease, but it can help you to feel better and return to normal activities. The disease eventually returns after surgery, and most people will need to keep taking medicines to control symptoms over the long term. However, between 85 and 90 percent of people have no symptoms during the year following surgery. Up to 20 percent of people have no symptoms 15 years after surgery. (See "Medical prophylaxis of postoperative Crohn's disease".)
The most commonly performed surgeries for Crohn's disease include:
In some cases, the surgeon will not be able to reconnect the two ends of the intestine. Instead, he or she will connect the intestines to an opening in the abdomen, called an ostomy (figure 2). Bodily waste will exit your body through the ostomy, rather than through your anus. You will wear a plastic bag on the outside of the ostomy to collect the waste, and you will empty the bag as needed.
In most cases, the ostomy is temporary and is reversed after your colon has healed for a few months. In other cases, a permanent ostomy is required.
The idea of an ostomy can be frightening. You will need to learn how to care for the ostomy, including how to care for the skin around the ostomy and fitting and emptying the bag that covers the ostomy. An ostomy nurse specialist is expert in the care of people with ostomies. With training, time, and support, it is possible to lead a normal life with an ostomy.
CROHN'S DISEASE AND LIFESTYLE
There might be certain foods or food groups that worsen your symptoms, particularly during flares, and it is reasonable to avoid these foods temporarily. However, eliminating entire food groups can lead to malnutrition. Talk to your doctor, nurse, or a dietitian for help in managing your diet.
Other lifestyle recommendations include the following:
Crohn's disease and colon cancer — Having Crohn's disease increases your risk of developing colorectal cancer. Your risk depends on how long you have had Crohn's disease and how much of your colon is affected. (See "Colorectal cancer surveillance in inflammatory bowel disease".)
To find colorectal cancer as soon as possible, most experts recommend that people with Crohn's disease start having colon cancer screening early and often. For some people, this might mean having a colonoscopy eight years after being diagnosed, and then once per year thereafter. (See "Patient information: Colonoscopy".)
Talk to your doctor or nurse to find out when you should start having colon cancer screening and how often it should be repeated. (See "Patient information: Colon cancer screening".)
PREGNANCY AND CROHN'S DISEASE
Pregnancy and Crohn's disease are discussed separately. (See "Patient information: Inflammatory bowel disease and pregnancy".)
CLINICAL TRIALS
New medicines are continually being developed to treat Crohn's disease. The majority of the new medicines that are being developed help control inflammation. Many of these drugs are currently undergoing clinical trials. As of yet, none have been proven to be better than currently available treatments. (See "Investigational therapies in the medical management of Crohn's disease".)
If you are interested in participating in a clinical trial, discuss this with your doctor or nurse or read more about clinical trials on the Internet (www.clinicaltrials.gov/).
WHERE TO GET MORE INFORMATION
Your healthcare provider is the best source of information for questions and concerns related to your medical problem.
This article will be updated as needed every four months on our Web site (www.uptodate.com/patients).
Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.
Patient level information
Patient information: Ulcerative colitis
Patient information: Irritable bowel syndrome
Patient information: Sulfasalazine and the 5-aminosalicylates
Patient information: Tuberculosis
Patient information: Quitting smoking
Patient information: Colonoscopy
Patient information: Colon cancer screening
Patient information: Inflammatory bowel disease and pregnancy
Professional level information
Certolizumab pegol for treatment of Crohn's disease in adults
Clinical manifestations of Crohn's disease in children and adolescents
Clinical manifestations, diagnosis and prognosis of Crohn's disease in adults
Colorectal cancer surveillance in inflammatory bowel disease
Fertility, pregnancy, and nursing in inflammatory bowel disease
Immunomodulator therapy in Crohn's disease
Infliximab in Crohn's disease
Investigational therapies in the medical management of Crohn's disease
Medical management of Crohn's disease in adults
Overview of the management of Crohn's disease in children and adolescents
Perianal complications of Crohn's disease
Skin and eye manifestations of inflammatory bowel disease
Surgical management of inflammatory bowel disease
Antibiotics for treatment of inflammatory bowel diseases
Medical prophylaxis of postoperative Crohn's disease
The following organizations also provide reliable health information.
(www.nlm.nih.gov/medlineplus/healthtopics.html)
(www.digestive.niddk.nih.gov/ddiseases/pubs/crohns/index.htm)
Patient support — There are a number of online forums where patients can find information and support from other people with similar conditions.
(http://ibdcrohns.about.com/forum)
[1-3]
![]() |
Please wait |
UpToDate performs a continuous review of over 440 journals and other resources. Updates are added as important new information is published. The literature review for version 18.2 is current through May 2010; this topic was last changed on March 5, 2010. The next version of UpToDate (18.3) will be released in November 2010.